Primary biliary cirrhosis: Incidence and predictive factors of cirrhosis development in ursodiol-treated patients

Gastroenterology

Volumn 122, Issue 3, 2002, Pages 652-658

  Corpechot, Christophe ^a   Carrat, Fabrice ^b   Poupon, Raoul ^a   Poupon, ReneeEugenie ^c  

^a Service d'Hépatologie   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BILIRUBIN; URSODEOXYCHOLIC ACID;

ALBUMIN BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; DRUG EFFICACY; FEMALE; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FAILURE; LYMPHOCYTOSIS; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

EID: 0036182838     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.31880     Document Type: Article

References (26)

1. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis
2. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis
3. The Canadian multicenter doubleblind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
4. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
5. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis
6. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis
7. Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: Results of a double-blind controlled multicentric trial
8. Ursodiol for the long-term treatment of primary biliary cirrhosis
9. Effects of ursodeoxycholic acid after 4 to 12 years of therapy in early and late stages of primary biliary cirrhosis
10. Prognostic factors and longterm effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis
11. Ten-year survival in ursodeoxycholic acidtreated patients with primary biliary cirrhosis
12. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis
13. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
14. Marshall G, Jones RH, Multi-state models and diabetic retinopathy
15. The Markov process in medical prognosis
16. Time course of histological progression in primary biliary cirrhosis
17. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial
18. Prognosis in primary biliary cirrhosis: Model for decision making
19. Effect of alcohol consumption on systemic markers of inflammation
20. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture
21. Characterization of mechanisms causing hypoalbuminemia in rats with long-term bile duct ligation
22. Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression
23. Semiquantitative assessment of cholestasis and lymphocytic piecemeal necrosis in primary biliary cirrhosis: A histologic and immunohistochemical study
24. Pathology of septum formation in primary biliary cirrhosis: A histological study in the non-cirrhotic stage
25. Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients
26. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features and response to therapy